OncLive | Bringing the Global Oncology Community Together

In the phase III PROSPER trial, investigators will attempt a novel approach in localized renal cell carcinoma: priming the immune system prior to nephrectomy with neoadjuvant nivolumab and continuing with adjuvant blockade.... Read More >>

Regorafenib/Nivolumab Combo to Be Explored in Phase III MSS CRC Trial

Preclinical Research Suggests Role for ITK Inhibition in Monocytic MDSCs in CLL

Ongoing Research With Novel Approaches Continues in Uterine Sarcomas

NTRK Gene Fusions: Finding the "Golden Ticket" in Oncology

CMS Unveils Proposed Radiation Oncology Model of Care

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

2019 State of the Science Summit on Hematologic Malignancies in Seattle

15th International Conference on Malignant Lymphoma

2019 European Hematology Association Congress

2019 ASCO Annual Meeting

Dr. El-Khoueiry on Choosing Between Immunotherapy Agents and TKIs in HCC

Dr. Redner on the Potency of Gilteritinib in AML

Dr. Yu on Initial Findings From the KEYNOTE-365 Trial in mCRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Stage III Melanoma: Neoadjuvant Therapy

Stage III Melanoma: Changes to Staging System

Genetic Risk, Screening, and Diagnosis for Gastric Cancer

Introduction and Global Trends of Gastric Cancer

MONALEESA-2 and Choosing Among the CDK4/6

Neoadjuvant Therapy in the Treatment of Melanoma

Melanoma: BRAF Status and a Neoadjuvant Therapy Approach

OncLive houses thousands of videos that provide updates and information.
See more Videos

Factors to Consider in Choosing ALK TKIs in Frontline Setting

ALK-Positive NSCLC: ASCEND-4 Trial

Safety/Efficacy Experience With Ramucirumab in HCC

VEGF-Targeted Therapy in HCC: Ramucirumab

Frontline-Therapy Decision Factors for mCRC

Approval-Inciting Data in Hepatocellular Carcinoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

New Directions in Chronic Lymphocytic Leukemia Care: A Review of 2019 Treatment Guideline Updates

Pivotal trial data were presented at the 2018 ASH Annual Meeting that demonstrated promising results for the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (SLL).

View more >>>

Featured

TRK Inhibitors: Precision Medicine in Oncology

Benjamin Levy, MD; Mark Agulnik, MD; Marcia Brose, MD, PhD; Edward Kim, MD; John Marshall, MD; and Philip Agop Philip, MD, PhD, FRCP, discuss the use of TRK inhibitors in oncology.

View more >>>

Featured Video

Advances in BRAF-Targeted Therapy for Metastatic Melanoma

Novel Combination Approaches for Metastatic Kidney Cancer

Geoffrey Thomas Gibney, MD; Ryan J. Sullivan, MD; Hussein A. Tawbi, MD, discuss advances in BRAF-targeted therapy for patients with metastatic melanoma. View now

FDA Approvals in Myeloma and ITP, Applications Accepted in Myeloma and More